Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Denver. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Denver at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
The main purpose of this study is to determine the safety, tolerability (how your body reacts to the drug) and effectiveness (ability to treat your cancer) of REGN5678 alone, or in combination with cemiplimab. The study has 2 parts. The goal of Part 1 (dose escalation) is to determine a safe dose(s) of REGN5678 when it is given alone or in combination with cemiplimab. The goal of Part 2 (dose expansion) is to use the REGN5678 drug dose(s) found in Part 1 to see how well REGN5678 alone or in com
Sponsor: Regeneron Pharmaceuticals
Check if you qualify for this prostate cancer clinical trial in Denver, CO
If you're searching for prostate cancer treatment options in Denver, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Denver research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.